Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle.

Innala E, Bäckström T, Poromaa IS, Andersson C, Bixo M.

Acta Obstet Gynecol Scand. 2012 Dec;91(12):1445-52. doi: 10.1111/j.1600-0412.2012.01536.x.

PMID:
22924787
2.

Reinstatement of serum pregnanolone isomers and progesterone during alcohol detoxification therapy in premenopausal women.

Hill M, Popov P, Havlikova H, Kancheva L, Vrbikova J, Meloun M, Kancheva R, Cibula D, Pouzar V, Cerny I, Starka L.

Alcohol Clin Exp Res. 2005 Jun;29(6):1010-7.

PMID:
15976527
3.
4.

Allopregnanolone in women with premenstrual syndrome.

Bicíková M, Dibbelt L, Hill M, Hampl R, Stárka L.

Horm Metab Res. 1998 Apr;30(4):227-30.

PMID:
9623639
5.

Allopregnanolone concentrations and premenstrual syndrome.

Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR.

Eur J Endocrinol. 2000 Mar;142(3):269-73.

6.

[Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women].

Zhou YZ, Jiang YX, Sun Q, Zhang SQ, Zhang Y, Chen FL, Lin SQ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Dec;23(6):609-13. Chinese.

PMID:
12901108
7.

Evaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyria.

Innala E, Bäckström T, Bixo M, Andersson C.

Acta Obstet Gynecol Scand. 2010;89(1):95-100. doi: 10.3109/00016340903390729.

PMID:
20021268
8.

Progesterone metabolite allopregnanolone in women with premenstrual syndrome.

Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB.

Obstet Gynecol. 1997 Nov;90(5):709-14.

PMID:
9351749
9.
10.

Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy.

Kancheva R, Hill M, Cibula D, Vceláková H, Kancheva L, Vrbíková J, Fait T, Parízek A, Stárka L.

J Endocrinol. 2007 Oct;195(1):67-78.

11.

Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects.

Genazzani AD, Luisi M, Malavasi B, Strucchi C, Luisi S, Casarosa E, Bernardi F, Genazzani AR, Petraglia F.

Eur J Endocrinol. 2002 Mar;146(3):347-56.

12.

Subnormal follicular-phase serum progesterone levels and elevated follicular-phase serum estradiol levels in young women with insulin-dependent diabetes.

Zumoff B, Miller L, Poretsky L, Levit CD, Miller EH, Heinz U, Denman H, Jandorek R, Rosenfeld RS.

Steroids. 1990 Dec;55(12):560-4.

PMID:
2089747
13.

Endocrine response to pregnanolone.

Sundström I, Bäckström T.

Gynecol Endocrinol. 1999 Oct;13(5):352-60.

PMID:
10599553
14.

Serum levels of relaxin during the menstrual cycle and oral contraceptive use.

Wreje U, Kristiansson P, Aberg H, Byström B, von Schoultz B.

Gynecol Obstet Invest. 1995;39(3):197-200.

PMID:
7789917
15.

The effect of smoking on serum progesterone, estradiol, and luteinizing hormone levels over a menstrual cycle in normal women.

Zumoff B, Miller L, Levit CD, Miller EH, Heinz U, Kalin M, Denman H, Jandorek R, Rosenfeld RS.

Steroids. 1990 Nov;55(11):507-11.

PMID:
2075617
16.

Serum allopregnanolone levels relate to FSFI score during the menstrual cycle.

Nappi RE, Abbiati I, Luisi S, Ferdeghini F, Polatti F, Genazzani AR.

J Sex Marital Ther. 2003;29 Suppl 1:95-102.

PMID:
12735093
17.

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.

Martinez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE, Cintron D, Thompson KD, Khine KK, Schmidt PJ.

Neuropsychopharmacology. 2016 Mar;41(4):1093-102. doi: 10.1038/npp.2015.246.

PMID:
26272051
18.

Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization.

Wu E, Xiao B, Yan W, Li H, Wu B.

Contraception. 1992 Jun;45(6):583-93.

PMID:
1617967
19.

Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.

Katkam RR, Gopalkrishnan K, Chwalisz K, Schillinger E, Puri CP.

Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):779-87.

PMID:
7573244
20.

Acute effects of triazolam in women: relationships with progesterone, estradiol and allopregnanolone.

de Wit H, Rukstalis M.

Psychopharmacology (Berl). 1997 Mar;130(1):69-78.

PMID:
9089849
Items per page

Supplemental Content

Support Center